KSR and regulators of RAS signaling in C elegans

描述（由申请人提供）：ras刺激的Raf/MEK/ERK激酶级联在正常动物发育和癌症中起关键作用。多种知之甚少的机制确保这个级联只在它应该出现的时间和地点被激活。越来越多的证据表明，支架对信号蛋白的区隔化是这种调节的重要组成部分。我们的研究使用秀丽隐杆线虫作为遗传模型系统来识别Raf/MEK/ERK信号的新调控因子并了解它们的功能。在之前的资助期内（04/01/00至03/31/05），我们证明了支架KSR在MEK/ERK激活中的重要和广泛作用，并且我们表明支架CNK促进了Raf激活的特定步骤。我们还发现了多个其他保守的，但以前未研究的基因产物，它们与KSR-1合作，促进对该信号级联的某些下游反应。在下一个资助期，我们将重点研究这些基因产物的几组，以了解信号蛋白的区隔化如何控制信号传播和特异性。在目标1中，我们将测试KSR-1和KSR-2相似物之间的内在功能差异是否有助于组织特异性反应。在Aim 2中，我们将确定支架CNK-1及其结合伙伴KIC-1在Raf激活和定位中的作用。膜易位和内吞作用是Raf激活和失活的关键步骤，我们将测试CNK-1和KIC-1参与这些过程的模型。在Aim 3中，我们将确定一个保守的泛素偶联（E2）酶在Ras信号传导和支架功能中的作用。我们将测试E2调节KSR或CNK支架或其他信号蛋白的运输和定位的模型，并确定其作用机制。在Aim 4中，我们将继续对新的Ras通路调节因子进行遗传和基于rnai的筛选，并选择最可能与KSR， CNK和/或E2蛋白一起起作用的调节因子进行进一步研究。我们的研究有望揭示Ras通路调控的新方面，阐明信号区隔化的机制和生物学相关性。Ras或Raf的异常信号是人类癌症最常见的原因之一。从长远来看，对Raf/MEK/ERK调控的详细了解将允许合理设计治疗方法来治疗此类癌症。

DESCRIPTION (provided by applicant): The Ras-stimulated Raf/MEK/ERK kinase cascade plays critical roles in normal animal development and cancer. Multiple poorly understood mechanisms ensure that this cascade is active only when and where it should be. Increasing evidence suggests that compartmentalization of signaling proteins by scaffolds is an important component of such regulation. Our research uses C. elegans as a genetic model system to identify new regulators of Raf/MEK/ERK signaling and understand how they function. During the previous funding period (04/01/00 to 3/31/05), we demonstrated the essential and widespread role of the scaffold KSR in MEK/ERK activation, and we showed that the scaffold CNK promotes a specific step of Raf activation. We also identified multiple other conserved, but previously unstudied, gene products that cooperate with KSR-1 to promote certain downstream responses to this signaling cascade. In the next funding period, we will focus on several sets of these gene products to understand how compartmentalization of signaling proteins controls signal propagation and specificity. In Aim 1, we will test if inherent functional differences between the KSR-1 and KSR-2 paralogs contribute to tissue-specific responses. In Aim 2, we will determine the role of the scaffold CNK-1 and its binding partner KIC-1 in Raf activation and localization. Membrane translocation and endocytosis are key steps in Raf activation and de-activation, and we will test the model that CNK-1 and KIC-1 are involved in these processes. In Aim 3, we will determine the role of a conserved ubiquitin conjugating (E2) enzyme in Ras signaling and scaffold function. We will test the model that this E2 regulates trafficking and localization of the KSR or CNK scaffolds, or of other signaling proteins, and we will identify the mechanism by which it acts. In Aim 4, we will continue both forward genetic and RNAi-based screens for new Ras pathway regulators, and choose for further study those mostly likely to function with KSR, CNK and/or our E2 protein. Our studies are expected to reveal new aspects of Ras pathway regulation and clarify the mechanisms and biological relevance of signaling compartmentalization. Aberrant signaling by Ras or Raf is 1 of the most frequent causes of human cancers. In the long term, a detailed understanding of Raf/MEK/ERK regulation will allow the rational design of therapeutic approaches to treat such cancers.